急性虚血性脳卒中診断・治療の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21APR0062)
◆英語タイトル:Global Acute Ischemic Stroke Diagnosis and Treatment Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR0062
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年4月
◆ページ数:98
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥499,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥748,800見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、急性虚血性脳卒中診断・治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(コンピュータ断層撮影(CT)、磁気共鳴画像法(MRI)、頸部超音波、脳血管造影、心電図、心エコー検査、その他)、用途別市場規模(組織プラスミノーゲン活性化因子、抗凝固剤、抗血小板剤、降圧剤)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・急性虚血性脳卒中診断・治療の市場動向
・企業の競争状況、市場シェア
・急性虚血性脳卒中診断・治療の種類別市場規模(コンピュータ断層撮影(CT)、磁気共鳴画像法(MRI)、頸部超音波、脳血管造影、心電図、心エコー検査、その他)
・急性虚血性脳卒中診断・治療の用途別市場規模(組織プラスミノーゲン活性化因子、抗凝固剤、抗血小板剤、降圧剤)
・急性虚血性脳卒中診断・治療の北米市場規模2016-2027(アメリカ、カナダ)
・急性虚血性脳卒中診断・治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・急性虚血性脳卒中診断・治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・急性虚血性脳卒中診断・治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・急性虚血性脳卒中診断・治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Abbott、Medtronic、Boston Scientific、Cordis、Philips、GE Healthcare、Siemens、Stryker、Genentech、Merck)
・結論
【レポートの概要】

According to a World Health Organization (WHO) estimate, around 17 million people die every year due to cardiovascular diseases.

Market Analysis and Insights: Global Acute Ischemic Stroke Diagnosis and Treatment Market
The global Acute Ischemic Stroke Diagnosis and Treatment market size is projected to reach US$ 1325.2 million by 2026, from US$ 1049.8 million in 2019, at a CAGR of 3.3% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acute Ischemic Stroke Diagnosis and Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acute Ischemic Stroke Diagnosis and Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acute Ischemic Stroke Diagnosis and Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acute Ischemic Stroke Diagnosis and Treatment market.

Global Acute Ischemic Stroke Diagnosis and Treatment Scope and Market Size
Acute Ischemic Stroke Diagnosis and Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acute Ischemic Stroke Diagnosis and Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Computed Tomography (CT)
Magnetic resonance imaging (MRI)
Carotid Ultrasound
Cerebral Angiography
Electrocardiography
Echocardiography
Others

Segment by Application
Tissue Plasminogen Activator
Anticoagulant
Antiplatelet
Antihypertensive

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott
Medtronic
Boston Scientific
Cordis
Philips
GE Healthcare
Siemens
Stryker
Genentech

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Ischemic Stroke Diagnosis and Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Computed Tomography (CT)
1.2.3 Magnetic resonance imaging (MRI)
1.2.4 Carotid Ultrasound
1.2.5 Cerebral Angiography
1.2.6 Electrocardiography
1.2.7 Echocardiography
1.2.8 Others
1.3 Market by Application
1.3.1 Global Acute Ischemic Stroke Diagnosis and Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Tissue Plasminogen Activator
1.3.3 Anticoagulant
1.3.4 Antiplatelet
1.3.5 Antihypertensive
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Acute Ischemic Stroke Diagnosis and Treatment Market Perspective (2016-2027)
2.2 Acute Ischemic Stroke Diagnosis and Treatment Growth Trends by Regions
2.2.1 Acute Ischemic Stroke Diagnosis and Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Acute Ischemic Stroke Diagnosis and Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Acute Ischemic Stroke Diagnosis and Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Acute Ischemic Stroke Diagnosis and Treatment Industry Dynamic
2.3.1 Acute Ischemic Stroke Diagnosis and Treatment Market Trends
2.3.2 Acute Ischemic Stroke Diagnosis and Treatment Market Drivers
2.3.3 Acute Ischemic Stroke Diagnosis and Treatment Market Challenges
2.3.4 Acute Ischemic Stroke Diagnosis and Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Acute Ischemic Stroke Diagnosis and Treatment Players by Revenue
3.1.1 Global Top Acute Ischemic Stroke Diagnosis and Treatment Players by Revenue (2016-2021)
3.1.2 Global Acute Ischemic Stroke Diagnosis and Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Acute Ischemic Stroke Diagnosis and Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Acute Ischemic Stroke Diagnosis and Treatment Revenue
3.4 Global Acute Ischemic Stroke Diagnosis and Treatment Market Concentration Ratio
3.4.1 Global Acute Ischemic Stroke Diagnosis and Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Ischemic Stroke Diagnosis and Treatment Revenue in 2020
3.5 Acute Ischemic Stroke Diagnosis and Treatment Key Players Head office and Area Served
3.6 Key Players Acute Ischemic Stroke Diagnosis and Treatment Product Solution and Service
3.7 Date of Enter into Acute Ischemic Stroke Diagnosis and Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Acute Ischemic Stroke Diagnosis and Treatment Breakdown Data by Type
4.1 Global Acute Ischemic Stroke Diagnosis and Treatment Historic Market Size by Type (2016-2021)
4.2 Global Acute Ischemic Stroke Diagnosis and Treatment Forecasted Market Size by Type (2022-2027)

5 Acute Ischemic Stroke Diagnosis and Treatment Breakdown Data by Application
5.1 Global Acute Ischemic Stroke Diagnosis and Treatment Historic Market Size by Application (2016-2021)
5.2 Global Acute Ischemic Stroke Diagnosis and Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Acute Ischemic Stroke Diagnosis and Treatment Market Size (2016-2027)
6.2 North America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type
6.2.1 North America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2016-2021)
6.2.2 North America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2022-2027)
6.2.3 North America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2016-2027)
6.3 North America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application
6.3.1 North America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2016-2021)
6.3.2 North America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2022-2027)
6.3.3 North America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2016-2027)
6.4 North America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Country
6.4.1 North America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Country (2016-2021)
6.4.2 North America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Acute Ischemic Stroke Diagnosis and Treatment Market Size (2016-2027)
7.2 Europe Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type
7.2.1 Europe Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2016-2021)
7.2.2 Europe Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2022-2027)
7.2.3 Europe Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2016-2027)
7.3 Europe Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application
7.3.1 Europe Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2016-2021)
7.3.2 Europe Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2022-2027)
7.3.3 Europe Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2016-2027)
7.4 Europe Acute Ischemic Stroke Diagnosis and Treatment Market Size by Country
7.4.1 Europe Acute Ischemic Stroke Diagnosis and Treatment Market Size by Country (2016-2021)
7.4.2 Europe Acute Ischemic Stroke Diagnosis and Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Size (2016-2027)
8.2 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type
8.2.1 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application
8.3.1 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Size by Region
8.4.1 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Acute Ischemic Stroke Diagnosis and Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Acute Ischemic Stroke Diagnosis and Treatment Market Size (2016-2027)
9.2 Latin America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type
9.2.1 Latin America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2016-2027)
9.3 Latin America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application
9.3.1 Latin America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2016-2027)
9.4 Latin America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Country
9.4.1 Latin America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Acute Ischemic Stroke Diagnosis and Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Market Size (2016-2027)
10.2 Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type
10.2.1 Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application
10.3.1 Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Market Size by Country
10.4.1 Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Acute Ischemic Stroke Diagnosis and Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Acute Ischemic Stroke Diagnosis and Treatment Introduction
11.1.4 Abbott Revenue in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Medtronic
11.2.1 Medtronic Company Details
11.2.2 Medtronic Business Overview
11.2.3 Medtronic Acute Ischemic Stroke Diagnosis and Treatment Introduction
11.2.4 Medtronic Revenue in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021)
11.2.5 Medtronic Recent Development
11.3 Boston Scientific
11.3.1 Boston Scientific Company Details
11.3.2 Boston Scientific Business Overview
11.3.3 Boston Scientific Acute Ischemic Stroke Diagnosis and Treatment Introduction
11.3.4 Boston Scientific Revenue in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021)
11.3.5 Boston Scientific Recent Development
11.4 Cordis
11.4.1 Cordis Company Details
11.4.2 Cordis Business Overview
11.4.3 Cordis Acute Ischemic Stroke Diagnosis and Treatment Introduction
11.4.4 Cordis Revenue in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021)
11.4.5 Cordis Recent Development
11.5 Philips
11.5.1 Philips Company Details
11.5.2 Philips Business Overview
11.5.3 Philips Acute Ischemic Stroke Diagnosis and Treatment Introduction
11.5.4 Philips Revenue in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021)
11.5.5 Philips Recent Development
11.6 GE Healthcare
11.6.1 GE Healthcare Company Details
11.6.2 GE Healthcare Business Overview
11.6.3 GE Healthcare Acute Ischemic Stroke Diagnosis and Treatment Introduction
11.6.4 GE Healthcare Revenue in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021)
11.6.5 GE Healthcare Recent Development
11.7 Siemens
11.7.1 Siemens Company Details
11.7.2 Siemens Business Overview
11.7.3 Siemens Acute Ischemic Stroke Diagnosis and Treatment Introduction
11.7.4 Siemens Revenue in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021)
11.7.5 Siemens Recent Development
11.8 Stryker
11.8.1 Stryker Company Details
11.8.2 Stryker Business Overview
11.8.3 Stryker Acute Ischemic Stroke Diagnosis and Treatment Introduction
11.8.4 Stryker Revenue in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021)
11.8.5 Stryker Recent Development
11.9 Genentech
11.9.1 Genentech Company Details
11.9.2 Genentech Business Overview
11.9.3 Genentech Acute Ischemic Stroke Diagnosis and Treatment Introduction
11.9.4 Genentech Revenue in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021)
11.9.5 Genentech Recent Development
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Merck Business Overview
11.10.3 Merck Acute Ischemic Stroke Diagnosis and Treatment Introduction
11.10.4 Merck Revenue in Acute Ischemic Stroke Diagnosis and Treatment Business (2016-2021)
11.10.5 Merck Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 急性虚血性脳卒中診断・治療の世界市場規模・現状・予測2021年-2027年(Global Acute Ischemic Stroke Diagnosis and Treatment Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。